Literature DB >> 17289802

Preanalytical mRNA stabilization of whole bone marrow samples.

Claudia Langebrake1, Kalle Günther, Jürgen Lauber, Dirk Reinhardt.   

Abstract

BACKGROUND: Gene expression profiling is a useful tool for cancer diagnosis and basic research. A major limitation is that, even during short-term storage of native specimens of peripheral blood or bone marrow (BM) and/or RNA isolation, significant changes of gene expression pattern can occur because of gene induction, repression, and RNA degradation.
METHODS: We investigated the effectiveness of a newly developed RNA stabilization and preparation system for BM specimens (PAXgene Bone Marrow RNA System) over time. We analyzed 256 RNA samples, processed from 64 BM specimens.
RESULTS: Although the overall RNA yield (normalized to 1 x 10(7) leukocytes) was not different, the RNA preparation using unstabilized reference samples had an approximately 3 times higher failure rate. With the PAXgene system, we observed significantly higher RNA integrity compared with the reference RNA preparation system (P <0.01). In the stabilized samples, we found very high pairwise correlation in gene expression (DeltaDeltaC(T) 0.16-0.53) for the analyzed genes (GATA1, RUNX1, NCAM1, and SPI1) after 48-h storage compared with immediate preparation of RNA (2 h after BM collection). However, we found major differences in half of the analyzed genes using the reference RNA isolation procedure (DeltaDeltaC(T) 1.07 and 1.32).
CONCLUSIONS: The PAXgene system is able to stabilize RNA from clinical BM samples and is suitable to isolate high-quality and -quantity RNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289802     DOI: 10.1373/clinchem.2006.078592

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Clinical usefulness of the PAXgene™ bone marrow RNA system for stabilizing total RNA.

Authors:  Mayu Takeda; Tadao Funato; Masaki Ikemoto; Toru Nanmoku; Yoshimasa Urasaki; Yoshinori Iwatani
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

3.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

4.  Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.

Authors:  Daniel Gilbert Weber; Swaantje Casjens; Peter Rozynek; Martin Lehnert; Sandra Zilch-Schöneweis; Oleksandr Bryk; Dirk Taeger; Maria Gomolka; Michaela Kreuzer; Heinz Otten; Beate Pesch; Georg Johnen; Thomas Brüning
Journal:  Biomark Insights       Date:  2010-09-22

5.  Influence of storage conditions of small volumes of blood on immune transcriptomic profiles.

Authors:  Rebecca Mathew; Mohammed Toufiq; Valentina Mattei; Muna Al Hashmi; Harshitha Shobha Manjunath; Basirudeen Syed Ahamed Kabeer; Rita Calzone; Chiara Cugno; Damien Chaussabel; Sara Deola; Sara Tomei
Journal:  BMC Res Notes       Date:  2020-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.